Targeted Delivery of MicroRNA125a-5p by Engineered Lipid Nanoparticles for the Treatment of HER2 Positive Metastatic Breast Cancer. [electronic resource]
Producer: 20160712Description: 554-68 p. digitalISSN:- 1550-7033
- Breast Neoplasms -- genetics
- Cell Line, Tumor
- Cell Survival -- drug effects
- Gene Targeting -- methods
- Genetic Therapy -- methods
- Humans
- Lipids -- chemistry
- MicroRNAs -- administration & dosage
- Nanocapsules -- chemistry
- Proto-Oncogene Mas
- Receptor, ErbB-2 -- genetics
- Transfection -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.